Kimberly Manhard
2020
Compensation breakdown
| Non-Equity Incentive Plan | $199,976 |
|---|---|
| Option Awards | $1,154,364 |
| Salary | $519,167 |
| Stock Awards | $314,400 |
| Other | $8,550 |
| Total | $2,196,457 |
Manhard received $1.2M in option awards, accounting for 53% of the total pay in 2020.
Manhard also received $200K in non-equity incentive plan, $519.2K in salary, $314.4K in stock awards and $8.6K in other compensation.
Rankings
In 2020, Kimberly Manhard's compensation ranked 5,098th out of 13,090 executives tracked by ExecPay. In other words, Manhard earned more than 61.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,098 out of 13,090 | 61st |
Division Manufacturing | 2,082 out of 5,620 | 63rd |
Major group Chemicals And Allied Products | 835 out of 2,253 | 63rd |
Industry group Drugs | 721 out of 1,953 | 63rd |
Industry Pharmaceutical Preparations | 543 out of 1,458 | 63rd |
Pay ratio
| Kimberly Manhard's Pay | $2,196,457 |
|---|---|
| Median Employee's Pay | $363,920 |
| Pay Ratio | 6to 1 |
In 2020, the annual total compensation of Kimberly Manhard was $2,196,457.
The annual total compensation of the median employee at Heron Therapeutics was $363,920.
The ratio of Kimberly Manhard's pay to the pay of median employee was therefore 6 to one.
Manhard's colleagues
We found five more compensation records of executives who worked with Kimberly Manhard at Heron Therapeutics in 2020.
2020
Barry Quart
Heron Therapeutics
Chief Executive Officer
2020
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
2020
David Szekeres
Heron Therapeutics
Chief Operating Officer
2020
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
2020
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
News
May 1, 2023
April 25, 2022
April 22, 2021
April 23, 2020